Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
The pharmacokinetic profile of PAI-039 indicated an oral bioavailability of 43 +/- 15
InChiKey: COABRICCWCYCPI-UHFFFAOYSA-N
Smiles: COC1C=C(CCC(=O)CC(=O)CCC2C=C(OC)C(O)=CC=2)C=CC=1O
Smiles: CO[C@H]1C=CC=C(C)C[C@H](C)[C@H](O)[C@H](C)C=C(C)C=C(C)C(=O)O[C@@H]1[C@@H](C)[C@@H](O)[C@H](C)[C@@]1(O)C[C@@H](OC(=O)/C=C/C(O)=O)[C@@H](C)[C@@H](CC)O1 |c:5
64(17):6207-13
PEG2-ethyl acetate enaline hydrochloride The pharmacokinetic profile of PAI-039PEG2 ethyl acetate is a PEG based PROTAC linker that can be used in the synthesis of PROTACs. Product information CAS Number: 154773 33 8 Molecular Weight: 192. 21 Formula: C8H16O5 Chemical Name: ethyl 2 [2 (2 hydroxyethoxy)ethoxy]acetate Smiles: CCOC(=O)COCCOCCO InChiKey: GHNWJTOZQSLFIF UHFFFAOYSA N InChi: InChI=1S C8H16O5 c1 2 13 8(10)7 12 6 5 11 4 3 9 h9H,2 7H2,1H3 Technical Data Appearance: Solid Power Purity: 98% (or refer to the Certificate of